Treatment of AML cell lines, primary blasts and CD34+CD38−CD123+ LSCs with MP-A08, a selective sphingosine kinase inhibitor, significantly induced apoptosis, with negligible effects on normal HSCs from healthy samples (99). This evidence concerns the gene CD34 and acute myeloid leukemia.